We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+15.2%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.84B
AUM Growth
+$226M
(+14%)
Cap. Flow
+$18.1M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
36.21%
Holding
2,856
New
200
Increased
717
Reduced
1,072
Closed
193
Avg Time Held Equity + Options
2.5
years
Top 10 Avg Time Held Equity + Options
1.7
years
Top 20 Avg Time Held Equity + Options
1.8
years
Avg Time Held Equity only
2.5
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$14.5M |
| 2 |
CVB Financial
CVBF
|
+$10.4M |
| 3 |
Uber
UBER
|
+$9.41M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$8.18M |
| 5 |
Snap
SNAP
|
+$7.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$18.3M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$14.1M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$5.32M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$4.53M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$4.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.33% |
| 2 | Technology | 13.72% |
| 3 | Financials | 8.08% |
| 4 | Healthcare | 7.07% |
| 5 | Consumer Discretionary | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2201
Signet Jewelers
SIG
$4.53B
| $3K | ﹤0.01% |
116
| – | – |
2020 Q2
2 quarters
|
|
2202
Silicon Motion
SIMO
$7.24B
| $3K | ﹤0.01% |
53
-90
| -63% | -$3.68K |
2017 Q3
13 quarters
|
|
2203
Sensient Technologies
SXT
$5.71B
| $3K | ﹤0.01% |
41
-43
| -51% | -$3K |
2016 Q4
16 quarters
|
|
2204
DELISTED
Theravance Biopharma
TBPH
| $3K | ﹤0.01% |
158
| – | – |
2016 Q4
16 quarters
|
|
2205
Teradata
TDC
$2.81B
| $3K | ﹤0.01% |
132
-358
| -73% | -$7.68K |
2016 Q4
16 quarters
|
|
2206
TG Therapeutics
TGTX
$8.29B
| $3K | ﹤0.01% |
64
+19
| +42% | +$642 |
2020 Q2
2 quarters
|
|
2207
DELISTED
Tri Pointe Homes
TPH
| $3K | ﹤0.01% |
167
| – | – |
2020 Q1
3 quarters
|
|
2208
10x Genomics
TXG
$9.07B
| $3K | ﹤0.01% |
+18
| New | +$2.61K |
2020 Q4
0 quarters
|
|
2209
Unifirst Corp
UNF
$4.71B
| $3K | ﹤0.01% |
12
| – | – |
2020 Q1
3 quarters
|
|
2210
Liberty All-Star Equity Fund
USA
$1.82B
| $3K | ﹤0.01% |
405
+10
| +3% | +$64 |
2020 Q2
2 quarters
|
|
2211
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.3B
| $3K | ﹤0.01% |
76
+52
| +217% | +$2.1K |
2020 Q3
1 quarter
|
|
2212
United States Lime & Minerals
USLM
$3.03B
| $3K | ﹤0.01% |
145
| – | – |
2016 Q4
16 quarters
|
|
2213
Cohen & Steers Infrastructure Fund
UTF
$2.87B
| $3K | ﹤0.01% |
104
| – | – |
2017 Q1
15 quarters
|
|
2214
Vishay Precision Group
VPG
$812M
| $3K | ﹤0.01% |
85
+83
| +4,150% | +$2.34K |
2016 Q4
16 quarters
|
|
2215
Vishay Intertechnology
VSH
$4.23B
| $3K | ﹤0.01% |
140
-95
| -40% | -$1.75K |
2016 Q4
16 quarters
|
|
2216
vTv Therapeutics
VTVT
$106M
| $3K | ﹤0.01% |
38
| – | – |
2020 Q2
2 quarters
|
|
2217
NCR Voyix
VYX
$1.04B
| $3K | ﹤0.01% |
119
-468
| -80% | -$7.76K |
2016 Q4
16 quarters
|
|
2218
Walker & Dunlop
WD
$1.12B
| $3K | ﹤0.01% |
32
| – | – |
2018 Q3
9 quarters
|
|
2219
WesBanco
WSBC
$3.56B
| $3K | ﹤0.01% |
107
-136
| -56% | -$3.67K |
2019 Q3
5 quarters
|
|
2220
TXNM Energy Inc
TXNM
$6.45B
| $3K | ﹤0.01% |
64
+19
| +42% | +$916 |
2016 Q4
16 quarters
|
|
2221
DELISTED
Stericycle Inc
SRCL
| $3K | ﹤0.01% |
43
-76
| -64% | -$5.2K |
2016 Q4
16 quarters
|
|
2222
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $3K | ﹤0.01% |
19
| – | – |
2020 Q2
2 quarters
|
|
2223
DELISTED
Apartment Income REIT Corp.
AIRC
| $3K | ﹤0.01% |
+90
| New | +$3.46K |
2020 Q4
0 quarters
|
|
2224
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $3K | ﹤0.01% |
38
+4
| +12% | +$257 |
2019 Q3
5 quarters
|
|
|
CCF
2225
DELISTED
Chase Corporation
CCF
| $3K | ﹤0.01% |
33
+19
| +136% | +$1.99K |
2020 Q1
3 quarters
|
|
Similar funds
Parallel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Parallel Advisors held 2,856 positions worth $1.84B, up 14% from $1.62B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q4 2020 filing shows 200 new, 717 increased, 1,072 reduced and 193 closed positions. Its largest new stake was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M. The largest sale was Microsoft, an estimated $18.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 56% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q4 2020 buy was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M.
- Parallel Advisors added most to iShares US Treasury Bond ETF in Q4 2020, an estimated $14.5M increase.
- Parallel Advisors's biggest Q4 2020 reduction was Microsoft, cutting an estimated $18.3M.
- Parallel Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $926K.
- Parallel Advisors's ten largest holdings make up 36% of its $1.84B portfolio in Q4 2020.
- Parallel Advisors opened 200 new positions and closed 193 in Q4 2020.
- Parallel Advisors's portfolio value rose 14% quarter-over-quarter to $1.84B.
Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.